ArticleMolecular neurobiology2025
Potential Risks of Minoxidil in Pheochromocytoma and Paraganglioma: A Commentary on Safety Concerns and Mechanisms.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pheochromocytoma and paraganglioma are neuroendocrine tumours characterised by excessive catecholamine release. Minoxidil, a potent vasodilator commonly used for hypertension and androgenetic alopecia, may exacerbate cardiovascular complications associated with pheochromocytoma due to its mechanisms-of-action. This commentary aims to elucidate the potential risks and safety concerns associated with the use of minoxidil in patients with pheochromocytoma. Here, we discuss the need for careful prescribing practices when considering minoxidil in pheochromocytoma-associated hypertension and the potential problems that minoxidil use may cause in pheochromocytoma patients.
Indexed as
Identifiers
40097761What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.